Show Notes
In the final episode of Season 2, we look at the future of healthcare in Central Europe and the Baltics, a diverse region that covers almost one third of EU countries.
Tuba Atahan, Managing Director, and Laura Saar, Market Access Director, for Central Europe and Baltics delve into the current barriers to healthcare access in the region – such as the growing disparity in multiple myeloma care – and discuss innovative solutions that will help close the gap.
This recording was organised and funded by Johnson & Johnson November 2024 CP-485355 | CP-485428 Hosted on Acast. See acast.com/privacy for more information.
More from Transforming Health
In this episode, we explore why health should be seen as an investment, that delivers positive returns for individuals, economies and society as a whole.
This episode focuses on precision medicine in cancer – why it’s considered so revolutionary, and how we can work together to make it more accessible to every patient.
In this episode, our experts shine a light on the benefits of endoscopy in the long-term management of inflammatory bowel disease (IBD).
In this episode, we talk about the importance of shared decision-making in helping patients achieve a “life of possibility”, especially in complex illnesses like multiple myeloma.
In this episode, we find out how the healthcare industry and academic institutions are working together to find solutions to a decreasing healthcare workforce.